{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:11:37Z","timestamp":1790655097927,"version":"4.1.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1038\/s41440-025-02401-x","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T05:13:15Z","timestamp":1759813995000},"page":"3244-3256","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Effects of perirenal fat accumulation on cardiometabolic and renal functions and mineralocorticoid receptor activation in primary aldosteronism"],"prefix":"10.1038","volume":"48","author":[{"given":"Ryunosuke","family":"Mitsuno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshifumi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kengo","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiki","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Mizutani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitake","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Jinzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuhiko","family":"Azegami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichiro","family":"Kinouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9833-4356","authenticated-orcid":false,"given":"Jun","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaori","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,7]]},"reference":[{"key":"2401_CR1","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1507\/endocrj.EJ21-0508","volume":"69","author":"M Naruse","year":"2022","unstructured":"Naruse M, Katabami T, Shibata H, Sone M, Takahashi K, Tanabe A, et al. Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021. Endocr J. 2022;69:327\u201359.","journal-title":"Endocr J"},{"key":"2401_CR2","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"JW Funder","year":"2016","unstructured":"Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101:1889\u2013916.","journal-title":"J Clin Endocrinol Metab"},{"key":"2401_CR3","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1038\/s41440-023-01288-w","volume":"46","author":"Y Yoshida","year":"2023","unstructured":"Yoshida Y, Shibata H. Recent progress in the diagnosis and treatment of primary aldosteronism. Hypertens Res. 2023;46:1738\u201344.","journal-title":"Hypertens Res"},{"key":"2401_CR4","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1161\/CIRCULATIONAHA.115.018226","volume":"132","author":"AC Huby","year":"2015","unstructured":"Huby AC, Antonova G, Groenendyk J, Gomez-Sanchez CE, Bollag WB, Filosa JA, et al. Adipocyte-derived hormone leptin is a direct regulator of aldosterone secretion, which promotes endothelial dysfunction and cardiac fibrosis. Circulation. 2015;132:2134\u201345.","journal-title":"Circulation"},{"key":"2401_CR5","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/sj.ijo.0803508","volume":"31","author":"S Schinner","year":"2007","unstructured":"Schinner S, Willenberg HS, Krause D, Schott M, Lamounier-Zepter V, Krug AW, et al. Adipocyte-derived products induce the transcription of the StAR promoter and stimulate aldosterone and cortisol secretion from adrenocortical cells through the Wnt-signaling pathway. Int J Obes. 2007;31:864\u201370.","journal-title":"Int J Obes"},{"key":"2401_CR6","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1161\/HYPERTENSIONAHA.111.190223","volume":"59","author":"AM Briones","year":"2012","unstructured":"Briones AM, Nguyen Dinh Cat A, Callera GE, Yogi A, Burger D, He Y, et al. Adipocytes produce aldosterone through calcineurin-dependent signaling pathways: implications in diabetes mellitus-associated obesity and vascular dysfunction. Hypertension. 2012;59:1069\u201378.","journal-title":"Hypertension"},{"key":"2401_CR7","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvad154","volume":"8","author":"R Mitsuno","year":"2023","unstructured":"Mitsuno R, Kaneko K, Nakamura T, Kojima D, Mizutani Y, Azegami T, et al. Association between renal sinus fat and cardiometabolic and renin-angiotensin system parameters in primary aldosteronism. J Endocr Soc. 2023;8:bvad154.","journal-title":"J Endocr Soc"},{"key":"2401_CR8","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/s41440-024-01970-7","volume":"48","author":"Y Yoshida","year":"2025","unstructured":"Yoshida Y, Shibata H. Evolution of mineralocorticoid receptor antagonists, aldosterone synthase inhibitors, and alternative treatments for managing primary aldosteronism. Hypertens Res. 2025;48:854\u201361.","journal-title":"Hypertens Res"},{"key":"2401_CR9","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/s41440-024-01997-w","volume":"48","author":"N Matsuda","year":"2025","unstructured":"Matsuda N, Yoshida Y, Inobe N, Yoshimura M, Iwamoto M, Nagai S, et al. Antihypertensive effects and changes in extracellular water content by mineralocorticoid receptor antagonists in patients with primary aldosteronism. Hypertens Res. 2025;48:553\u201362.","journal-title":"Hypertens Res"},{"key":"2401_CR10","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/s41440-022-01143-4","volume":"46","author":"H Shibata","year":"2023","unstructured":"Shibata H. Adrenal ablation therapy for unilateral primary aldosteronism: pros and cons. Hypertens Res. 2023;46:787\u20139.","journal-title":"Hypertens Res"},{"key":"2401_CR11","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvab020","volume":"5","author":"Y Yoshida","year":"2021","unstructured":"Yoshida Y, Yoshida R, Shibuta K, Ozeki Y, Okamoto M, Gotoh K, et al. Quality of life of primary aldosteronism patients by mineralocorticoid receptor antagonists. J Endocr Soc. 2021;5:bvab020.","journal-title":"J Endocr Soc"},{"key":"2401_CR12","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1097\/00004872-199917040-00014","volume":"17","author":"S Engeli","year":"1999","unstructured":"Engeli S, Gorzelniak K, Kreutz R, Runkel N, Distler A, Sharma AM. Co-expression of renin-angiotensin system genes in human adipose tissue. J Hypertens. 1999;17:555\u201360.","journal-title":"J Hypertens"},{"key":"2401_CR13","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/sj.ijo.0800821","volume":"23","author":"P Schling","year":"1999","unstructured":"Schling P, Mallow H, Trindl A, Loffler G. Evidence for a local renin angiotensin system in primary cultured human preadipocytes. Int J Obes Relat Metab Disord. 1999;23:336\u201341.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"2401_CR14","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1161\/HYPERTENSIONAHA.110.168872","volume":"58","author":"A Nguyen Dinh Cat","year":"2011","unstructured":"Nguyen Dinh Cat A, Briones AM, Callera GE, Yogi A, He Y, Montezano AC, et al. Adipocyte-derived factors regulate vascular smooth muscle cells through mineralocorticoid and glucocorticoid receptors. Hypertension. 2011;58:479\u201388.","journal-title":"Hypertension"},{"key":"2401_CR15","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1038\/s41440-023-01170-9","volume":"46","author":"T Haze","year":"2023","unstructured":"Haze T, Ozawa M, Kawano R, Haruna A, Ohki Y, Suzuki S, et al. Effect of the interaction between the visceral-to-subcutaneous fat ratio and aldosterone on cardiac function in patients with primary aldosteronism. Hypertens Res. 2023;46:1132\u201344.","journal-title":"Hypertens Res"},{"key":"2401_CR16","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1038\/s41440-021-00719-w","volume":"44","author":"T Haze","year":"2021","unstructured":"Haze T, Hatakeyama M, Komiya S, Kawano R, Ohki Y, Suzuki S, et al. Association of the ratio of visceral-to-subcutaneous fat volume with renal function among patients with primary aldosteronism. Hypertens Res. 2021;44:1341\u201351.","journal-title":"Hypertens Res"},{"key":"2401_CR17","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1210\/js.2018-00187","volume":"2","author":"Y Shibayama","year":"2018","unstructured":"Shibayama Y, Wada N, Baba S, Miyano Y, Obara S, Iwasaki R, et al. Relationship between visceral fat and plasma aldosterone concentration in patients with primary aldosteronism. J Endocr Soc. 2018;2:1236\u201345.","journal-title":"J Endocr Soc"},{"key":"2401_CR18","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1177\/0003319718799967","volume":"70","author":"BX Liu","year":"2019","unstructured":"Liu BX, Sun W, Kong XQ. Perirenal fat: a unique fat pad and potential target for cardiovascular disease. Angiology. 2019;70:584\u201393.","journal-title":"Angiology"},{"key":"2401_CR19","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1111\/jch.13370","volume":"20","author":"MA Ricci","year":"2018","unstructured":"Ricci MA, Scavizzi M, Ministrini S, De Vuono S, Pucci G, Lupattelli G. Morbid obesity and hypertension: the role of perirenal fat. J Clin Hypertens. 2018;20:1430\u20137.","journal-title":"J Clin Hypertens"},{"key":"2401_CR20","doi-asserted-by":"publisher","first-page":"115","DOI":"10.4239\/wjd.v11.i4.115","volume":"11","author":"N Huang","year":"2020","unstructured":"Huang N, Mao EW, Hou NN, Liu YP, Han F, Sun XD. Novel insight into perirenal adipose tissue: a neglected adipose depot linking cardiovascular and chronic kidney disease. World J Diabetes. 2020;11:115\u201325.","journal-title":"World J Diabetes"},{"key":"2401_CR21","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1111\/jch.13366","volume":"20","author":"G Geraci","year":"2018","unstructured":"Geraci G, Zammuto MM, Mattina A, Zanoli L, Geraci C, Granata A, et al. Para-perirenal distribution of body fat is associated with reduced glomerular filtration rate regardless of other indices of adiposity in hypertensive patients. J Clin Hypertens. 2018;20:1438\u201346.","journal-title":"J Clin Hypertens"},{"key":"2401_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.850334","volume":"13","author":"XL Guo","year":"2022","unstructured":"Guo XL, Tu M, Chen Y, Wang W. Perirenal fat thickness: a surrogate marker for metabolic syndrome in chinese newly diagnosed type 2 Diabetes. Front Endocrinol. 2022;13:850334.","journal-title":"Front Endocrinol"},{"key":"2401_CR23","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1093\/cvr\/cvp191","volume":"84","author":"A Hirata","year":"2009","unstructured":"Hirata A, Maeda N, Hiuge A, Hibuse T, Fujita K, Okada T, et al. Blockade of mineralocorticoid receptor reverses adipocyte dysfunction and insulin resistance in obese mice. Cardiovasc Res. 2009;84:164\u201372.","journal-title":"Cardiovasc Res"},{"key":"2401_CR24","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1161\/HYPERTENSIONAHA.114.04981","volume":"66","author":"R Urbanet","year":"2015","unstructured":"Urbanet R, Nguyen Dinh Cat A, Feraco A, Venteclef N, El Mogrhabi S, Sierra-Ramos C, et al. Adipocyte mineralocorticoid receptor activation leads to metabolic syndrome and induction of prostaglandin D2 synthase. Hypertension. 2015;66:149\u201357.","journal-title":"Hypertension"},{"key":"2401_CR25","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","volume":"53","author":"S Matsuo","year":"2009","unstructured":"Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982\u201392.","journal-title":"Am J Kidney Dis"},{"key":"2401_CR26","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/s41440-019-0284-9","volume":"42","author":"S Umemura","year":"2019","unstructured":"Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019). Hypertens Res. 2019;42:1235\u2013481.","journal-title":"Hypertens Res"},{"key":"2401_CR27","doi-asserted-by":"publisher","first-page":"329","DOI":"10.7326\/0003-4819-151-5-200909010-00007","volume":"151","author":"MJ Kempers","year":"2009","unstructured":"Kempers MJ, Lenders JW, van Outheusden L, van der Wilt GJ, Schultze Kool LJ, Hermus AR, et al. Systematic review: diagnostic procedures to differentiate unilateral from bilateral adrenal abnormality in primary aldosteronism. Ann Intern Med. 2009;151:329\u201337.","journal-title":"Ann Intern Med"},{"key":"2401_CR28","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.orcp.2024.03.005","volume":"18","author":"K Kaneko","year":"2024","unstructured":"Kaneko K, Mitsuno R, Kojima D, Azegami T, Kosugi S, Nakamura T, et al. Renal sinus fat is associated with intrarenal hemodynamic abnormalities independent of visceral fat in patients with chronic kidney disease. Obes Res Clin Pract. 2024;18:118\u201323.","journal-title":"Obes Res Clin Pract"},{"key":"2401_CR29","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1159\/000518254","volume":"52","author":"K Droebner","year":"2021","unstructured":"Droebner K, Pavkovic M, Grundmann M, Hartmann E, Goea L, Nordlohne J, et al. Direct blood pressure-independent anti-fibrotic effects by the selective nonsteroidal mineralocorticoid receptor antagonist finerenone in progressive models of kidney fibrosis. Am J Nephrol. 2021;52:588\u2013601.","journal-title":"Am J Nephrol"},{"key":"2401_CR30","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.3389\/fphar.2018.01131","volume":"9","author":"R Gonzalez-Blazquez","year":"2018","unstructured":"Gonzalez-Blazquez R, Somoza B, Gil-Ortega M, Martin Ramos M, Ramiro-Cortijo D, Vega-Martin E, et al. Finerenone attenuates endothelial dysfunction and albuminuria in a chronic kidney disease model by a reduction in oxidative stress. Front Pharm. 2018;9:1131.","journal-title":"Front Pharm"},{"key":"2401_CR31","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1126\/science.abe9985","volume":"372","author":"M Yoshino","year":"2021","unstructured":"Yoshino M, Yoshino J, Kayser BD, Patti GJ, Franczyk MP, Mills KF, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021;372:1224\u20139.","journal-title":"Science"},{"key":"2401_CR32","doi-asserted-by":"publisher","first-page":"23822","DOI":"10.1073\/pnas.1909917116","volume":"116","author":"S Yamaguchi","year":"2019","unstructured":"Yamaguchi S, Franczyk MP, Chondronikola M, Qi N, Gunawardana SC, Stromsdorfer KL, et al. Adipose tissue NAD(+) biosynthesis is required for regulating adaptive thermogenesis and whole-body energy homeostasis in mice. Proc Natl Acad Sci USA. 2019;116:23822\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2401_CR33","doi-asserted-by":"publisher","unstructured":"Qi N, Franczyk MP, Yamaguchi S, Kojima D, Hayashi K, Satoh A, et al. Adipocyte-specific inactivation of NAMPT, a key NAD(+) biosynthetic enzyme, causes a metabolically-unhealthy lean phenotype in female mice during aging. Am J Physiol Endocrinol Metab. 2024;(e-pub ahead of print 20240529;https:\/\/doi.org\/10.1152\/ajpendo.00313.2023.","DOI":"10.1152\/ajpendo.00313.2023"},{"key":"2401_CR34","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.amjcard.2005.03.085","volume":"96","author":"T McLaughlin","year":"2005","unstructured":"McLaughlin T, Reaven G, Abbasi F, Lamendola C, Saad M, Waters D, et al. Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease? Am J Cardiol. 2005;96:399\u2013404.","journal-title":"Am J Cardiol"},{"key":"2401_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.707126","volume":"12","author":"SH Hammoud","year":"2021","unstructured":"Hammoud SH, AlZaim I, Al-Dhaheri Y, Eid AH, El-Yazbi AF. Perirenal adipose tissue inflammation: novel insights linking metabolic dysfunction to renal diseases. Front Endocrinol. 2021;12:707126.","journal-title":"Front Endocrinol"},{"key":"2401_CR36","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1210\/en.2017-00651","volume":"159","author":"C Wu","year":"2018","unstructured":"Wu C, Zhang H, Zhang J, Xie C, Fan C, Zhang H, et al. Inflammation and fibrosis in perirenal adipose tissue of patients with aldosterone-producing adenoma. Endocrinology. 2018;159:227\u201337.","journal-title":"Endocrinology"},{"key":"2401_CR37","first-page":"1339","volume":"8","author":"G Zhou","year":"2016","unstructured":"Zhou G, Johansson U, Peng XR, Bamberg K, Huang Y. An additive effect of eplerenone to ACE inhibitor on slowing the progression of diabetic nephropathy in the db\/db mice. Am J Transl Res. 2016;8:1339\u201354.","journal-title":"Am J Transl Res"},{"key":"2401_CR38","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1161\/HYPERTENSIONAHA.112.203158","volume":"60","author":"AJ Rickard","year":"2012","unstructured":"Rickard AJ, Morgan J, Bienvenu LA, Fletcher EK, Cranston GA, Shen JZ, et al. Cardiomyocyte mineralocorticoid receptors are essential for deoxycorticosterone\/salt-mediated inflammation and cardiac fibrosis. Hypertension. 2012;60:1443\u201350.","journal-title":"Hypertension"},{"key":"2401_CR39","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s40519-018-0532-z","volume":"24","author":"C Manno","year":"2019","unstructured":"Manno C, Campobasso N, Nardecchia A, Triggiani V, Zupo R, Gesualdo L, et al. Relationship of para- and perirenal fat and epicardial fat with metabolic parameters in overweight and obese subjects. Eat Weight Disord. 2019;24:67\u201372.","journal-title":"Eat Weight Disord"},{"key":"2401_CR40","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1093\/ndt\/gfq522","volume":"26","author":"O Lamacchia","year":"2011","unstructured":"Lamacchia O, Nicastro V, Camarchio D, Valente U, Grisorio R, Gesualdo L, et al. Para- and perirenal fat thickness is an independent predictor of chronic kidney disease, increased renal resistance index and hyperuricaemia in type-2 diabetic patients. Nephrol Dial Transpl. 2011;26:892\u20138.","journal-title":"Nephrol Dial Transpl"},{"key":"2401_CR41","doi-asserted-by":"publisher","first-page":"365","DOI":"10.23876\/j.krcp.18.0155","volume":"38","author":"L D\u2019Marco","year":"2019","unstructured":"D\u2019Marco L, Salazar J, Cortez M, Salazar M, Wettel M, Lima-Martinez M, et al. Perirenal fat thickness is associated with metabolic risk factors in patients with chronic kidney disease. Kidney Res Clin Pract. 2019;38:365\u201372.","journal-title":"Kidney Res Clin Pract"},{"key":"2401_CR42","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/294594","volume":"2013","author":"CS Hung","year":"2013","unstructured":"Hung CS, Ho YL, Chang YY, Wu VC, Wu XM, Lee JK, et al. Twenty-four-hour urinary aldosterone predicts inappropriate left ventricular mass index in patients with primary aldosteronism. Sci World J. 2013;2013:294594.","journal-title":"Sci World J"},{"key":"2401_CR43","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/j.clinbiochem.2014.05.062","volume":"47","author":"YY Chang","year":"2014","unstructured":"Chang YY, Lee HH, Hung CS, Wu XM, Lee JK, Wang SM, et al. Association between urine aldosterone and diastolic function in patients with primary aldosteronism and essential hypertension. Clin Biochem. 2014;47:1329\u201332.","journal-title":"Clin Biochem"},{"key":"2401_CR44","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1677\/JOE-09-0292","volume":"204","author":"J Hoppmann","year":"2010","unstructured":"Hoppmann J, Perwitz N, Meier B, Fasshauer M, Hadaschik D, Lehnert H, et al. The balance between gluco- and mineralo-corticoid action critically determines inflammatory adipocyte responses. J Endocrinol. 2010;204:153\u201364.","journal-title":"J Endocrinol"},{"key":"2401_CR45","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1161\/CIRCULATIONAHA.107.748640","volume":"117","author":"C Guo","year":"2008","unstructured":"Guo C, Ricchiuti V, Lian BQ, Yao TM, Coutinho P, Romero JR, et al. Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor-gamma, and proinflammatory adipokines. Circulation. 2008;117:2253\u201361.","journal-title":"Circulation"},{"key":"2401_CR46","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/nrneph.2013.110","volume":"9","author":"NJ Brown","year":"2013","unstructured":"Brown NJ. Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis. Nat Rev Nephrol. 2013;9:459\u201369.","journal-title":"Nat Rev Nephrol"},{"key":"2401_CR47","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1038\/hr.2014.77","volume":"37","author":"G Shlomai","year":"2014","unstructured":"Shlomai G, Sella T, Sharabi Y, Leibowitz A, Grossman E. Serum potassium levels predict blood pressure response to aldosterone antagonists in resistant hypertension. Hypertens Res. 2014;37:1037\u201341.","journal-title":"Hypertens Res"},{"key":"2401_CR48","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1097\/HJH.0000000000000870","volume":"34","author":"L Ghazi","year":"2016","unstructured":"Ghazi L, Dudenbostel T, Lin CP, Oparil S, Calhoun DA. Urinary sodium excretion predicts blood pressure response to spironolactone in patients with resistant hypertension independent of aldosterone status. J Hypertens. 2016;34:1005\u201310.","journal-title":"J Hypertens"},{"key":"2401_CR49","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1161\/HYPERTENSIONAHA.118.11818","volume":"73","author":"M Siddiqui","year":"2019","unstructured":"Siddiqui M, Judd EK, Jaeger BC, Bhatt H, Dudenbostel T, Zhang B, et al. Out-of-clinic sympathetic activity is increased in patients with masked uncontrolled hypertension. Hypertension. 2019;73:132\u201341.","journal-title":"Hypertension"},{"key":"2401_CR50","doi-asserted-by":"publisher","first-page":"e0228787","DOI":"10.1371\/journal.pone.0228787","volume":"15","author":"M Murabayashi","year":"2020","unstructured":"Murabayashi M, Daimon M, Murakami H, Fujita T, Sato E, Tanabe J, et al. Association between higher urinary normetanephrine and insulin resistance in a Japanese population. PLoS ONE. 2020;15:e0228787.","journal-title":"PLoS ONE"},{"key":"2401_CR51","doi-asserted-by":"crossref","unstructured":"Parasiliti-Caprino M, Obert C, Lopez C, Bollati M, Bioletto F, Bima C, et al. Association of urine metanephrine levels with cardiometabolic risk: an observational retrospective study. J Clin Med. 2021;10:1967.","DOI":"10.3390\/jcm10091967"},{"key":"2401_CR52","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1373\/clinchem.2014.224832","volume":"60","author":"G Eisenhofer","year":"2014","unstructured":"Eisenhofer G, Peitzsch M. Laboratory evaluation of pheochromocytoma and paraganglioma. Clin Chem. 2014;60:1486\u201399.","journal-title":"Clin Chem"},{"key":"2401_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30868-6","volume":"13","author":"P Li","year":"2022","unstructured":"Li P, Liu B, Wu X, Lu Y, Qiu M, Shen Y, et al. Perirenal adipose afferent nerves sustain pathological high blood pressure in rats. Nat Commun. 2022;13:3130.","journal-title":"Nat Commun"},{"key":"2401_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-023-07249-5","volume":"24","author":"M Li","year":"2023","unstructured":"Li M, Shi J, Sheng Y, Zhang Y, Wu T, Yang J, et al. Effect of focused power ultrasound-mediated perirenal fat modification on primary hypertension: protocol of a multicenter, randomized, double-blinded, sham-controlled study. Trials. 2023;24:221.","journal-title":"Trials"},{"key":"2401_CR55","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1097\/HJH.0000000000003479","volume":"41","author":"JY Sheu","year":"2023","unstructured":"Sheu JY, Wang SM, Wu VC, Huang KH, Tseng CS, Lee YJ, et al. Estimated glomerular filtration rate-dip after medical target therapy associated with increased mortality and cardiovascular events in patients with primary aldosteronism. J Hypertens. 2023;41:1401\u201310.","journal-title":"J Hypertens"},{"key":"2401_CR56","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1161\/HYPERTENSIONAHA.119.13131","volume":"74","author":"H Kobayashi","year":"2019","unstructured":"Kobayashi H, Abe M, Nakamura Y, Takahashi K, Fujita M, Takeda Y, et al. Association between acute fall in estimated glomerular filtration rate after treatment for primary aldosteronism and long-term decline in renal function. Hypertension. 2019;74:630\u20138.","journal-title":"Hypertension"},{"key":"2401_CR57","doi-asserted-by":"publisher","first-page":"e965","DOI":"10.1210\/clinem\/dgad709","volume":"109","author":"JY Chen","year":"2024","unstructured":"Chen JY, Huang KH, Lin YH, Chueh JS, Wang HY, Wu VC. Association of Dip in eGFR with clinical outcomes in unilateral primary aldosteronism patients after adrenalectomy. J Clin Endocrinol Metab. 2024;109:e965\u2013e74.","journal-title":"J Clin Endocrinol Metab"},{"key":"2401_CR58","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/nrneph.2012.19","volume":"8","author":"I Helal","year":"2012","unstructured":"Helal I, Fick-Brosnahan GM, Reed-Gitomer B, Schrier RW. Glomerular hyperfiltration: definitions, mechanisms and clinical implications. Nat Rev Nephrol. 2012;8:293\u2013300.","journal-title":"Nat Rev Nephrol"},{"key":"2401_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115661","volume":"168","author":"M Sanz-Gomez","year":"2023","unstructured":"Sanz-Gomez M, Manzano-Lista FJ, Vega-Martin E, Gonzalez-Moreno D, Alcala M, Gil-Ortega M, et al. Finerenone protects against progression of kidney and cardiovascular damage in a model of type 1 diabetes through modulation of proinflammatory and osteogenic factors. Biomed Pharmacother. 2023;168:115661.","journal-title":"Biomed Pharmacother"},{"key":"2401_CR60","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1161\/ATVBAHA.115.307031","volume":"36","author":"JY Sun","year":"2016","unstructured":"Sun JY, Li C, Shen ZX, Zhang WC, Ai TJ, Du LJ, et al. Mineralocorticoid receptor deficiency in macrophages inhibits neointimal hyperplasia and suppresses macrophage inflammation through SGK1-AP1\/NF-kappaB pathways. Arterioscler Thromb Vasc Biol. 2016;36:874\u201385.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2401_CR61","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1159\/000480652","volume":"46","author":"Z Belden","year":"2017","unstructured":"Belden Z, Deiuliis JA, Dobre M, Rajagopalan S. The role of the mineralocorticoid receptor in inflammation: focus on kidney and vasculature. Am J Nephrol. 2017;46:298\u2013314.","journal-title":"Am J Nephrol"},{"key":"2401_CR62","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.clnu.2017.04.007","volume":"37","author":"H Zelicha","year":"2018","unstructured":"Zelicha H, Schwarzfuchs D, Shelef I, Gepner Y, Tsaban G, Tene L, et al. Changes of renal sinus fat and renal parenchymal fat during an 18-month randomized weight loss trial. Clin Nutr. 2018;37:1145\u201353.","journal-title":"Clin Nutr"},{"key":"2401_CR63","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1159\/000538996","volume":"17","author":"G Cuatrecasas","year":"2024","unstructured":"Cuatrecasas G, Calbo M, Rossell O, Dachs L, Aguilar-Soler G, Coves MJ, et al. Effect of Liraglutide in different abdominal fat layers measured by ultrasound: the importance of perirenal fat reduction. Obes Facts. 2024;17:347\u201354.","journal-title":"Obes Facts"},{"key":"2401_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-61590-6","volume":"14","author":"G Cuatrecasas","year":"2024","unstructured":"Cuatrecasas G, De Cabo F, Coves MJ, Patrascioiu I, Aguilar G, Cuatrecasas G, et al. Dapagliflozin added to metformin reduces perirenal fat layer in type 2 diabetic patients with obesity. Sci Rep. 2024;14:10832.","journal-title":"Sci Rep"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-025-02401-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-025-02401-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-025-02401-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T23:01:55Z","timestamp":1764889315000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-025-02401-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,7]]},"references-count":64,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2401"],"URL":"https:\/\/doi.org\/10.1038\/s41440-025-02401-x","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,7]]},"assertion":[{"value":"16 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}